Medicinal herbs inhibit prostate cancer (PCa) via PI3 kinase and p21 mechanisms

被引：0
|
作者：
Huang, E-Chu [1 ]
Chen, Guoxun [1 ]
Baek, Seung J. [2 ]
McEntee, Michael F. [2 ]
Whelan, Jay [1 ]
机构：
[1] Univ Tennessee, Dept Nutr, Knoxville, TN 37996 USA
[2] Univ Tennessee, Dept Pathobiol, Knoxville, TN USA
来源：
FASEB JOURNAL | 2010年 / 24卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The Tumor Suppressor p53 Fine-Tunes Reactive Oxygen Species Levels and Neurogenesis via PI3 Kinase Signaling
    Forsberg, Kirsi
    Wuttke, Anja
    Quadrato, Giorgia
    Chumakov, Peter M.
    Wizenmann, Andrea
    Di Giovanni, Simone
    JOURNAL OF NEUROSCIENCE, 2013, 33 (36): : 14318 - 14330
  • [32] Galectin-3 facilitates the stability of p21 protein through carbohydrate recognition domain in prostate cancer cells
    Wang, Yi
    Raz, Avraham
    CANCER RESEARCH, 2012, 72
  • [33] Downregulation of GLYR1 contributes to microsatellite instability colorectal cancer by targeting p21 via the p38MAPK and PI3K/AKT pathways
    Zhiyan Hu
    Ting Long
    Yidan Ma
    Jiaxian Zhu
    Lingfang Gao
    Yan Zhong
    Xia Wang
    Xiaoyan Wang
    Zuguo Li
    Journal of Experimental & Clinical Cancer Research, 39
  • [34] Downregulation of GLYR1 contributes to microsatellite instability colorectal cancer by targeting p21 via the p38MAPK and PI3K/AKT pathways
    Hu Zhiyan
    Long Ting
    Ma Yidan
    Zhu Jiaxian
    Gao Lingfang
    Zhong Yan
    Wang Xia
    Wang Xiaoyan
    Li Zuguo
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 39 (01)
  • [35] Phase II trial of the PI3 kinase inhibitor BKM120 with or without enzalutamide in men with metastatic castration resistant prostate cancer (mCRPC).
    Armstrong, Andrew J.
    Halabi, Susan
    Healy, Patrick
    Alumkal, Joshi J.
    Yu, Evan Y.
    Winters, Carolyn
    Hobbs, Carey
    Soleau, Colleen
    Slottke, Rachel
    Mundy, Kelly
    George, Daniel J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [36] Phase II trial of the PI3 kinase inhibitor buparlisib (BKM-120) with or without enzalutamide in men with metastatic castration resistant prostate cancer
    Armstrong, Andrew J.
    Halabi, Susan
    Healy, Patrick
    Alumkal, Joshi J.
    Winters, Carolyn
    Kephart, Julie
    Bitting, Rhonda L.
    Hobbs, Carey
    Soleau, Colleen F.
    Beer, Tomasz M.
    Slottke, Rachel
    Mundy, Kelly
    Yu, Evan Y.
    George, Daniel J.
    EUROPEAN JOURNAL OF CANCER, 2017, 81 : 228 - 236
  • [37] Synergistic apoptosis induced by combined PI3 kinase and bcl-xl inhibition in genotypic subsets of prostate cancer is attenuated by a feedback signaling loop via the alpha-5 integrin
    Ren, Wenying
    Joshi, Raghav
    Mathew, Paul
    CANCER RESEARCH, 2016, 76
  • [38] PI3 Kinase p110 Delta Is Required for Leukemic Cell Survival and Self-Renewal in t(8;21) Acute Myeloid Leukemia
    Ostrodka, Leanne
    Samuel, Michael
    Sinclair, Taneisha
    Bhuiyan, Redwan
    Gritsman, Kira
    BLOOD, 2016, 128 (22)
  • [39] Polyphyllin I induces cell cycle arrest in prostate cancer cells via the upregulation of IL6 and P21 expression
    Zhang, Denglu
    Liu, Shuai
    Liu, Zhiyong
    Ma, Chenchen
    Jiang, Yuehua
    Sun, Chao
    Li, Kailin
    Cao, Guangshang
    Lin, Zhaomin
    Wang, Peng
    Zhang, Jianye
    Xu, Dawei
    Kong, Feng
    Zhao, Shengtian
    MEDICINE, 2019, 98 (44) : e17743
  • [40] The CC chemokine receptor-3 transduces signals via the p21 family of small G proteins Rho and Rac, and the p21-activated kinase PAK
    Vita, R
    Stafford, S
    Alam, R
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (01) : S92 - S92
12345